Hemolysis: all 186 studies
Page 1 of 2. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.
- Pneumatic Tube System Versus Personnel Transport and the Hemolysis Index of Emergency Department Blood Samples: A Randomized, Split-Sample, Single-Blind TrialRecruitingNCT07755007Not applicable
- Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric HemorrhageRecruitingNCT07466719Not applicable
- A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 GlomerulopathyRecruitingNCT07416162
- Feasibility Performance Study of ABL90 FLEX PLUS HEMRecruitingNCT07345091
- National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic AnemiaRecruitingNCT07019038
- Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal AnemiaRecruitingNCT06984445
- UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic AnemiaNot yet recruitingNCT06920446Early Phase 1
- Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With DogsRecruitingNCT06861816Not applicable
- Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in HemodialysisRecruitingNCT06806891Not applicable
- A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic AnemiaNot yet recruitingNCT06770504Phase 1
- Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic AnemiaNot yet recruitingNCT06743854
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.RecruitingNCT06733610Phase 1
- Modeling Blood Management and Hemolytic Risk in Pediatric Heart SurgeryRecruitingNCT06721455
- Study of Acquired Hemolytic Anemia in Adult Hospitalized PatientsNot yet recruitingNCT06708728
- SISIPUSH: Evaluation of Hemolysis and Iatrogenic Anemia Using the Push-pull Method to Obtain Blood from Pediatric Patients with Central Venous CathetersRecruitingNCT06657534Not applicable
- Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood CoagulationNot yet recruitingNCT06619093
- Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic ToxinsNot yet recruitingNCT06595680Phase 2
- A Phase 1 Clinical Trial of NTQ5082 in Healthy VolunteersNot yet recruitingNCT06560593Phase 1
- Effect of Food of NTQ5082 in Healthy SubjectsNot yet recruitingNCT06558656Phase 1
- Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular HemolysisRecruitingNCT06449001Phase 3
- Vivifrail Program on the Degree of Debilitation in Hospitalized Patients After Venous Hemolysis in Acute Ischemic StrokeRecruitingNCT06391502Not applicable
- Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney InjuryRecruitingNCT06349577Not applicable
- Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia CohortRecruitingNCT06341582
- Ravulizumab in Pregnancies Complicated by Severe Hypertensive DisordersRecruitingNCT06333652Phase 2
- Biodex Training in Hemodialysis Females With OsteopeniaRecruitingNCT06223802Not applicable
- CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of TherapyRecruitingNCT06212154Phase 1
- Renal Function and Hemolysis After Pulsed-field Ablation for Atrial FibrillationRecruitingNCT06198933
- Hemolysis During Pulsed-field and Radiofrequency AblationNot yet recruitingNCT06096428
- A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism DisordersRecruitingNCT06092346
- The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic AnemiaRecruitingNCT06021977Phase 2
- French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy"RecruitingNCT05991245
- Danicopan Early Access ProgramAvailableNCT05982938
- Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune NeutropeniaRecruitingNCT05931718
- Zanubrutinib in the Treatment of Relapsed/Refractory wAIHARecruitingNCT05922839Phase 2
- Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic SyndromeRecruitingNCT05726916Phase 3
- Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBLRecruitingNCT05694312Phase 2
- A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNHRecruitingNCT05539248Phase 1/2
- Second-line Treatment of Primary Autoimmune Hemolytic AnemiaRecruitingNCT05057468Phase 3
- Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of NewbornRecruitingNCT04218318Not applicable
- A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic AnemiaEnrolling by invitationNCT04138927Phase 3
- Wise Practice of Chinese Hemodialysis (WISHES)RecruitingNCT03001921
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
- Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)TerminatedNCT04661033Phase 2Results posted
- Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)CompletedNCT04469465Phase 3Results posted
- To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).TerminatedNCT04253236Phase 2Results posted
- Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist DeviceTerminatedNCT04199793Not applicableResults posted
- Clinical Trial to Assess the Effectiveness of Applying Dry Local Heat and/ or High Tourniquet Pressure for Venipuncture.CompletedNCT04027218Not applicableResults posted
- A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHACompletedNCT03764618Phase 3Results posted
- Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant RecipientsCompletedNCT03518203Phase 2Results posted
- Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)CompletedNCT03439839Phase 2Results posted
- Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis AccessTerminatedNCT03300024Not applicableResults posted
- Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)CompletedNCT03226678Phase 2Results posted
- Sildenafil To Prevent ClotCompletedNCT03199612Early Phase 1Results posted
- Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT03131219Phase 3Results posted
- A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)TerminatedNCT03075878Phase 1/2Results posted
- Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT02949128Phase 3Results posted
- Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and TreatmentTerminatedNCT02614898Results posted
- Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax MalariaCompletedNCT02216123Phase 3Results posted
- An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic SyndromeCompletedNCT01194973Phase 2Results posted
- An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic SyndromeCompletedNCT01193348Phase 2Results posted
- Glutamine Therapy for Hemolysis-Associated Pulmonary HypertensionCompletedNCT01048905Phase 2Results posted
- Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUSCompletedNCT00844844Phase 2Results posted
- Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUSCompletedNCT00844545Phase 2Results posted
- Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUSCompletedNCT00844428Phase 2Results posted
- Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)CompletedNCT00838513Phase 2Results posted
- Sirolimus for Autoimmune Disease of Blood CellsCompletedNCT00392951Phase 1/2Results posted
- Early vs. Late Tourniquet Release and Phlebotomy-Induced Hemolysis in the Emergency Department: TOURNI-EDCompletedNCT07617103Not applicable
- CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.Active, not recruitingNCT06231368Phase 1
- Diet Therapy in Hemodialysis PatientsCompletedNCT06215339Not applicable
- The Effect of Coolsense Method on Pain and Comfort in Hemodialysis PatientsCompletedNCT06144801Not applicable
- The Effect Of Vıdeo-Based Fıstula Care Educatıon On HemodıalysısCompletedNCT05962268Not applicable
- Dietary Fiber and Hyperkalemia in Dialysis PatientsCompletedNCT05860491
- Effect of Triflow Breathing TrainingCompletedNCT05809765Not applicable
- Electric Polarization of Red Blood Cells : A Cohort Study to Assess the Erythrocytes Membrane Integrity Through Charge Conservation, Following Cardiac Surgery.WithdrawnNCT05754294
- Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patients With Autoimmune Hemolytic Anemia.Status unknownNCT05711264
- Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part IIStatus unknownNCT05647200Not applicable
- CPB Prime Fluid Strategies to Preserve Mcirocirculatory PerfusionCompletedNCT05647057Not applicable
- Neonatal Cord Blood Screening for HDNStatus unknownNCT05617612
- Laughter Therapy Application in Hemodialysis PatientsCompletedNCT05576701Not applicable
- A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUSCompletedNCT05569746Phase 2
- Causes and Mechanisms of Space Hemolysis At High AltitudesCompletedNCT05496309
- Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis PopulationStatus unknownNCT05480436Phase 4
- End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal HemolysisStatus unknownNCT05475223Not applicable
- A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNHActive, not recruitingNCT05389449Phase 3
- A Longitudinal Study to Analyse the Correlation Between CAI and BilirubinStatus unknownNCT05287607
- A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and VasculitisStatus unknownNCT05263817Early Phase 1
- Detection of Group A β-Hemolytic Streptococci in Oral SamplesStatus unknownNCT05223634
- Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in ChinaCompletedNCT05125341
- Water Soluble Vitamins and Trace Elements Loss in Hemodiafiltration PatientsCompletedNCT05099185
- Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus ErythematosusStatus unknownNCT05057481Phase 3
- The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic AnemiaCompletedNCT05004259Phase 1
- A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseCompletedNCT04987489Phase 2
- Pyruvate Kinase (PK) Deficiency Global Longitudinal Registry: Patient-Reported Outcomes (PRO)TerminatedNCT04964323
- Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic AnemiaWithdrawnNCT04956276Phase 2
- Protective Antibody Level After COVID-19 Vaccination Among Patients Under HemodialysisCompletedNCT04871945
- Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU)CompletedNCT04859608Phase 3
- Parvovirus B19 Infection in Hereditary Hemolytic Anemias PatientsStatus unknownNCT04822090
- Therapeutic Orientation Test in Thrombotic MicroangiopathyCompletedNCT04777435Not applicable
- Observational Study of Elizaria® in aHUS PatientsCompletedNCT04749810
- A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)Active, not recruitingNCT04624659Phase 3